Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease.

Miller AH, Sastry G, Speranza AJ Jr, Lawlor BA, Mohs RC, Ryan TM, Gabriel SM, Serby M, Schmeidler J, Davis KL.

Am J Psychiatry. 1994 Feb;151(2):267-70.

PMID:
8296902
2.

[Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].

Matsunaga H, Sarai M.

Seishin Shinkeigaku Zasshi. 2000;102(4):367-98. Review. Japanese.

PMID:
10892305
3.

Pharmacological modulation of cortisol secretion and dexamethasone suppression in Alzheimer's disease.

Davous P, Roudier M, Piketty ML, Abramowitz C, Lamour Y.

Biol Psychiatry. 1988 Jan 1;23(1):13-24.

PMID:
3337850
4.

Cortisol and Alzheimer's disease, I: Basal studies.

Davis KL, Davis BM, Greenwald BS, Mohs RC, Mathé AA, Johns CA, Horvath TB.

Am J Psychiatry. 1986 Mar;143(3):300-5.

PMID:
3953862
5.

[Cortisol suppression after dexamethasone administration in patients with dementia].

Charles G, Mirel J, Lefevre A.

Encephale. 1986 May-Jun;12(3):105-10. French.

PMID:
3769855
6.

Suppression of cortisol following dexamethasone in demented patients.

Charles GA, Lefevre A, Mirel J, Rush AJ.

Psychiatry Res. 1986 Mar;17(3):173-82.

PMID:
3704025
7.

The dexamethasone suppression test in dementia: a review of the literature.

Skare S, Pew B, Dysken M.

J Geriatr Psychiatry Neurol. 1990 Jul-Sep;3(3):124-38. Review.

PMID:
2282129
8.

The dexamethasone suppression test in patients with mood disorders.

Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR Jr, Weissenburger JE, Crowley GT, Khatami M, Vasavada N.

J Clin Psychiatry. 1996 Oct;57(10):470-84. Review.

PMID:
8909334
9.

The dexamethasone suppression test in the clinical setting.

Evans DL, Burnett GB, Nemeroff CB.

Am J Psychiatry. 1983 May;140(5):586-9.

PMID:
6342422
10.

Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.

Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.

Arch Gen Psychiatry. 1984 Mar;41(3):257-67.

PMID:
6367690
11.

Cortisol and Alzheimer's disease.

Davous P.

Am J Psychiatry. 1987 Apr;144(4):533-5. No abstract available.

PMID:
3565637
12.
13.

Nonsuppression of cortisol in depression and immune function.

Syvälahti E, Eskola J, Ruuskanen O, Laine T.

Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(4):413-22.

PMID:
4070644
14.

ACTH and cortisol secretion in patients with Alzheimer's disease.

Franceschi M, Airaghi L, Gramigna C, Truci G, Manfredi MG, Canal N, Catania A.

J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):836-7.

15.

Dexamethasone suppression test: use of two different dexamethasone doses.

Hwang S, Zander J, Garvey M.

J Clin Psychiatry. 1984 Sep;45(9):390-2.

PMID:
6469924
16.

A subtle disturbance in the feedback regulation of the hypothalamic-pituitary-adrenal axis in the early phase of Alzheimer's disease.

Näsman B, Olsson T, Viitanen M, Carlström K.

Psychoneuroendocrinology. 1995;20(2):211-20.

PMID:
7899539
17.

The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression.

Asnis GM, Halbreich U, Ryan ND, Rabinowicz H, Puig-Antich J, Nelson B, Novacenko H, Friedman JH.

Psychoneuroendocrinology. 1987;12(4):295-301.

PMID:
3659228
18.
19.
20.

Multisteroid analysis after DST in depressed patients--a controlled study.

Holsboer F, Philipp M, Steiger A, Gerken A.

J Affect Disord. 1986 May-Jun;10(3):241-9.

PMID:
2943779

Supplemental Content

Support Center